October 2024 | Oncimmune announces the raise of a minimum of £2.0 million equity and an amendment to the facility agreement with IPF Partners, including a partial conversion of debt to equity
September 2024 | Poxel Announces an agreement with OrbiMed to monetize a portion of TWYMEEG® royalties for US$50 million and the restructuring of the IPF Partners debt facility
August 2024 – Caresyntax raises $180 million funding to accelerate growth and adoption of precision surgery
